- Brand: Actoplus MET, Actoplus MET XRGeneric: Pioglitazone Hcl and Metformin Hcl
- Brand: ActosGeneric: Pioglitazone Hydrochloride
- Brand: DuetactGeneric: Pioglitazone Hydrochloride and Glimepiride Tablets
- Brand: OseniGeneric: Alogliptin and Pioglitazone Tablets
- Brand: NesinaGeneric: Alogliptin Tablets
- Brand: JanuviaGeneric: Sitagliptin Phosphate
- Brand: JuvisyncGeneric: Sitagliptin and Simvastatin
- Brand: BydureonGeneric: Exenatide
- Brand: TradjentaGeneric: Linagliptin
- Brand: TanzeumGeneric: Albiglutide Pen for Injection, for Subcutaneous Use
- Brand: KazanoGeneric: Alogliptin and Metformin HCl Tablets
- Brand: InvokametGeneric: Canagliflozin and Metformin Hydrochloride Tablets
- Brand: FarxigaGeneric: Dapagliflozin Film-coated Tablets
- Brand: Invokamet XRGeneric: canagliflozin and metformin hydrochloride
- Brand: InvokanaGeneric: Canagliflozin Tablets
- Brand: JardianceGeneric: Empagliflozin Tablets
- Brand: OnglyzaGeneric: Saxagliptin Tablets
- Brand: WelcholGeneric: Colesevelam Hcl
- Brand: Xultophy InjectionGeneric: Insulin Degludec and Liraglutide
- Brand: NovoLog Mix 70/30Generic: Insulin Aspart Protamine and Insulin Aspart (rDNA origin)
- Brand: PrandinGeneric: Repaglinide
- Brand: Kombiglyze XRGeneric: Saxagliptin and Metformin HCl Extended-Release
- Brand: AvandametGeneric: Rosiglitazone Maleate and Metformin HCl
- Brand: AvandarylGeneric: Rosiglitazone Maleate and Glimepiride
- Brand: AvandiaGeneric: Rosiglitazone Maleate
- Brand: AdlyxinGeneric: Lixisenatide Injection
- Brand: GlyxambiGeneric: Empagliflozin and Linagliptin Tablets
- Brand: Janumet XRGeneric: Sitagliptin and Metformin HCl
- Brand: QsymiaGeneric: Phentermine and Topiramate
- Brand: QternGeneric: Dapagliflozin and Saxagliptin Tablets, for Oral Use
- Brand: JanumetGeneric: Sitagliptin Metformin HCL
- Brand: Qudexy XRGeneric: Topiramate Extended-Release Capsules
- Brand: Trokendi XRGeneric: Topiramate Extended-release Capsules
- Brand: TrulicityGeneric: Dulaglutide Injection, for Subcutaneous Use
- Brand: TopamaxGeneric: Topiramate
- Brand: JentaduetoGeneric: Linagliptin and Metformin Hydrochloride
- Brand: Jentadueto XRGeneric: Linagliptin and Metformin Hydrochloride Extended-release Tablets
- Brand: TresibaGeneric: Insulin Degludec Injection
Slideshows, Images, and Quizzes
- Picture of Polycystic Ovary SyndromeSource: RxList
View an Illustration of Picture of Polycystic Ovary Syndrome and learn more about Medical Anatomy.
Diseases, Conditions, and Procedures
- Types of Diabetes Type 2 MedicationsSource: MedicineNet
Consumer information about the types of type 2 diabetes medications. Read about the side effects of Precose, Diabinese, Amaryl, Glucophage, Actos, Avandia, Starlix, Prandin, and more. Drug interactions, dosing, storage, and breastfeeding and pregnancy safety information is provided.
- Diabetes Treatment: Medication, Diet, and InsulinSource: MedicineNet
Treatment of type 1 and type 2 diabetes and prediabetes include insulin, a diabetic diet, exercise, and medication. Guidelines for diabetes treatment varies by person. Learn about specific medications including side effects, and diet plan programs for diabetes, and other diabetes treatment options.
- Fatty Liver (NASH)Source: MedicineNet
Nonalcoholic fatty liver disease, or NASH, is a disease due to an abnormal accumulation of fat within the liver. Eventually, NASH scars the liver, and it ultimately leads to cirrhosis or liver cancer. Usually, NASH causes no symptoms, but later in the progression of the disease, it may cause jaundice, blood clots, and coma. Treatment for fatty liver includes diet, exercise, medication, and surgery.
- Lipodystrophy (Acquired, Generalized, Inherited)Source: MedicineNet
Lipodystrophy is a syndrome in which body fat tissue is lost or abnormally accumulated in the whole body or just areas of it. Three forms of this disease are genetic (familial), acquired due to previous infections or HIV treatment), and congenital (present at birth). Diabetics often get it if they inject insulin in the same spot over a period of time.
- Type 2 DiabetesSource: MedicineNet
Type 2 diabetes is a condition in which the cells cannot use blood sugar efficiently to meet the body’s needs. Symptoms include excessive thirst, frequent urination and weight loss, but many people don't know they have it without a blood test. Treatment options include medications, a type 2 diabetes diet, and other lifestyle changes.
- Oral Diabetes Prescription MedicationsSource: RxList
What are oral diabetes medications and how do they work? Side effects, types and different among diabetes medications, warnings, and precautions are described. Some examples of oral medications used for diabetes are also included.
- Oral Diabetes Prescription MedicationsSource: WebMD Feature Archive
Information on types of prescription oral diabetes medications. Side effects, drug interactions, and patient information is included.
- Exenatide-Pioglitazone Combo Tops Insulin in Type 2 DiabetesSource: WebMD Health News
A combination of pioglitazone and the glucagonlike peptide 1 (GLP-1) agonist exenatide (Bydureon, AstraZeneca) may represent an effective and safe alternative to insulin for the treatment of type 2 diabetes in patients who are poorly controlled despite use of both metformin and a sulfonylurea.
- Pioglitazone's Diabetes-Preventing Effects Persist Up to a YearSource: RxList
The protective effects of pioglitazone against diabetes continue for up to a year after patients with impaired glucose tolerance stop taking it, new research shows.
- FDA Still Sees Bladder Cancer Risk With PioglitazoneSource: WebMD Health News
The US Food and Drug Administration (FDA) said today that it still believes the type 2 diabetes drug pioglitazone (Actos, Takeda Pharmaceuticals) may pose an increased risk for bladder cancer after updating its review of published research, which has gone back and forth on the issue.
- Stopping Progression to DiabetesSource: WebMD Health News
In patients with prediabetes determined to be at high risk of progression to diabetes through oral glucose testing, treatment with a triple regimen of medications significantly reduced the likelihood of progression to type 2 diabetes compared with lifestyle modifications alone, according to new research.
- FDA OKs Generic Actos for Type 2 DiabetesSource: WebMD Health News
According to the CDC, about 26 million Americans have diabetes. The FDA today approved the first generic version of Actos to treat adults with type 2 diabetes.
- FDA Approves Three New Drug Treatments for Type 2 DiabetesSource: FDA
- Sitagliptin is 'Safest' DPP-4 Inhibitor for Type 2 DiabetesSource: WebMD Health News
A deeper dive into data from the Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) with the type 2 diabetes drug sitagliptin (Januvia, Merck), confirming that the dipeptidyl peptidase-4 (DPP-4) is not associated with any risk of developing heart failure in diabetic patients at high cardiovascular risk, has been published in JAMA Cardiology.
- Manufacturers of Some Diabetes Drugs to Strengthen Warning on Heart Failure RiskSource: FDA
Read about FDA's increased heart failure risk warnings on Type 2 diabetes drugs on RxList.
- NIH Study Offers Hope to Patients with Nonalcoholic SteatohepatitisSource: FDA
A study by the National Institutes of Health (NIH) offers hope to patients with nonalcoholic steatohepatitis (NASH).
- Now Novo Says Semaglutide Cuts CV Risk: SUSTAIN-6 Top-line DataSource: WebMD Health News
Just over a month after Novo Nordisk announced positive top-line results for liraglutide (Victoza, Novo Nordisk), showing that it significantly reduced the risk of major adverse cardiovascular events in the LEADER Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results—A Long Term Evaluation (LEADER) trial, the company has announced another positive study of a similar agent — both are glucagonlike peptide-1 (GLP-1) agonists for the treatment of type 2 diabetes; this time it is a once-weekly product called semaglutide, which is not yet approved anywhere.
- FDA Approves Adlyxin to Treat Type 2 DiabetesSource: FDA
The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.
- FDA Approves Farxiga to Treat Type 2 DiabetesSource: FDA
The U.S. Food and Drug Administration today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
- FDA Approves Jardiance to Treat Type 2 DiabetesSource: FDA
The U.S. Food and Drug Administration today approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes.
- FDA Approves New Treatment for Type 2 DiabetesSource: FDA
The U.S. Food and Drug Administration today approved Tradjenta (linagliptin) tablets, used with diet and exercise, to improve blood glucose control in adults with Type 2 diabetes.
- FDA Approves Tanzeum to Treat Type 2 DiabetesSource: FDA
The U.S. Food and Drug Administration today approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
- FDA Reviewing Preliminary Safe Information On ActosSource: FDA
The diabetes drug Actos (pioglitazone) is under FDA review due to its association with bladder cancer.